Clinical Trials in New York

Showing 15741-15760 of 22,668 trials

Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder

NCT00211744

A 12-week program to examine the effectiveness of topiramate in adjunctive treatment for adults with obsessive-compulsive disorder and who are currently on serotonin reuptake inhibitor medications (ages 18-65).

Obsessive-compulsive Disorder

Montefiore Medical Center24 participantsStarted Aug 2004

New York, New York, United States

COMPLETED< 1 mile

Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)

NCT00754117

Newly diagnosed DLCL patients will have baselne FDG-PET as part of initial staging (PET-1). Patients will then undergo 2 cycles of chemotherapy with R/CHOP. 14 to 21 days following cycle 2 of R/CHOP, patients will undergo repeat FDG-PET scan (PET-2). They will then complete therapy as planned. Following completion of therapy, standard response assessment will be performed, including CT scans of the chest, abdomen and pelvis and FDG-PET scan (PET-3).

Diffuse Large B-cell Lymphoma

Weill Medical College of Cornell University8 participantsStarted May 2008

New York, New York, United States

TERMINATEDPhase 1< 1 mile

Thrombolysis in Pediatric Stroke (TIPS)

NCT01591096

Thrombolysis in Pediatric Stroke (TIPS) is a five-year multi-center international safety and dose-finding study of intravenous (IV) tPA in children with acute ischemic stroke (AIS) to determine the maximal safe dose of intravenous Tissue Plasminogen Activator (IV-tPA) among three doses (0.75. 0.9, 1.0 mg/kg) for children age 2-17 years within 4.5 hours from onset of acute AIS.

Stroke

Seattle Children's Hospital1 participantsStarted Oct 2012

Palo Alto, California, United States • Aurora, Colorado, United States • Boston, Massachusetts, United States +12 more locations

Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder

Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)

Thrombolysis in Pediatric Stroke (TIPS)

Find Trials by Condition in New York

Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Resident Observed Burnout After Daily Supplementation With Coffee

Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

Safety of Oral Anticoagulants Registry

A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture Adhesive

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine

Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home